Home About us Contact
|
Home About us Contact | ||
|
|
||
Microporous Membrane (microporou + membrane)
Selected AbstractsA study on membrane distillation by a solar thermal-driven systemHEAT TRANSFER - ASIAN RESEARCH (FORMERLY HEAT TRANSFER-JAPANESE RESEARCH), Issue 7 2007Tsung-Ching Chen Abstract Membrane distillation (MD) is a membrane separation process that has long been investigated in small scale laboratory studies and has the potential to become a viable tool for water desalination. MD is a separation process that combines simultaneous mass and heat transfer through a hydrophobic microporous membrane. A solar collector is used in direct contact membrane distillation (DCMD) to heat seawater as a temperature driving force in heat transfer to establish seawater desalting systems. The effect of the temperature difference makes the brine vaporize in the hot fluid side and condense in the cold fluid side. The optimal operating parameters on the pure water production rate will also be examined in this study. The purposes of this study are to develop the theoretical heat and mass transfer formulations, simulate heat transfer rate of solar collector with internal fins in membrane distillation, and investigate the mass-transfer efficiency improvement in membrane distillation with the brine flow rate, solar collector efficiency, and temperature difference between both sides of membrane as parameters. © 2007 Wiley Periodicals, Inc. Heat Trans Asian Res, 36(7): 417,428, 2007; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/htj.20172 [source] Transport characteristics of L -citrulline in renal apical membrane of proximal tubular cellsBIOPHARMACEUTICS AND DRUG DISPOSITION, Issue 3 2009Keisuke Mitsuoka Abstract L -Citrulline has diagnostic potential for renal function, because its plasma concentration increases with the progression of renal failure. Although L -citrulline extracted by glomerular filtration in kidney is mostly reabsorbed, the mechanism involved is not clearly understood. The present study was designed to characterize L -citrulline transport across the apical membranes of renal epithelial tubular cells, using primary-cultured rat renal proximal tubular cells, as well as the human kidney proximal tubular cell line HK-2. L -Citrulline was transported in a Na+ -dependent manner from the apical side of both cell types cultured on permeable supports with a microporous membrane. Kinetic analysis indicated that the transport involves two distinct Na+ -dependent saturable systems and one Na+ -independent saturable system in HK-2 cells. The uptake was competitively inhibited by neutral and cationic, but not anionic amino acids. Relatively large cationic and anionic compounds inhibited the uptake, but smaller ones did not. In HK-2 cells, mRNA expression of SLC6A19 and SLC7A9, which encode B0AT1 and b0,+AT, respectively, was detected by RT-PCR. In addition, L -citrulline transport was significantly decreased in HK-2 cells in which either SLC6A19 or SLC7A9 was silenced. Hence, these results suggest that amino acid transporters B0AT1 and b0,+AT are involved in the reabsorption of L -citrulline in the kidney, at least in part, by mediating the apical membrane transport of L -citrulline in renal tubule cells. Copyright © 2009 John Wiley & Sons, Ltd. [source] A microfluidic bioreactor with integrated transepithelial electrical resistance (TEER) measurement electrodes for evaluation of renal epithelial cellsBIOTECHNOLOGY & BIOENGINEERING, Issue 4 2010Nicholas Ferrell Abstract We have developed a bilayer microfluidic system with integrated transepithelial electrical resistance (TEER) measurement electrodes to evaluate kidney epithelial cells under physiologically relevant fluid flow conditions. The bioreactor consists of apical and basolateral fluidic chambers connected via a transparent microporous membrane. The top chamber contains microfluidic channels to perfuse the apical surface of the cells. The bottom chamber acts as a reservoir for transport across the cell layer and provides support for the membrane. TEER electrodes were integrated into the device to monitor cell growth and evaluate cell,cell tight junction integrity. Immunofluorescence staining was performed within the microchannels for ZO-1 tight junction protein and acetylated ,-tubulin (primary cilia) using human renal epithelial cells (HREC) and MDCK cells. HREC were stained for cytoskeletal F-actin and exhibited disassembly of cytosolic F-actin stress fibers when exposed to shear stress. TEER was monitored over time under normal culture conditions and after disruption of the tight junctions using low Ca2+ medium. The transport rate of a fluorescently labeled tracer molecule (FITC-inulin) was measured before and after Ca2+ switch and a decrease in TEER corresponded with a large increase in paracellular inulin transport. This bioreactor design provides an instrumented platform with physiologically meaningful flow conditions to study various epithelial cell transport processes. Biotechnol. Bioeng. 2010;107:707,716. © 2010 Wiley Periodicals, Inc. [source] Human thymic epithelial cells maintain long-term survival of clonogenic myeloid and erythroid progenitor cells in vitroBRITISH JOURNAL OF HAEMATOLOGY, Issue 1 2000Katsuto Takenaka Precursor cells that migrate into the thymus are still multipotent. Therefore, thymic epithelial cells (TECs) may provide microenvironments not only for T-cell development, but also for maintenance of multipotent precursor cells until they undergo T-cell commitment. In the present study, we performed long-term cultures of CD34+ bone-marrow (BM) cells on TEC lines that were derived from cortical epithelial cells of post-natal thymus, to investigate whether human TECs could maintain long-term non-lymphoid haematopoiesis. Haematopoietic cells maintained in direct contact with established TEC lines were able to generate clonogenic progeny to both myeloid and erythroid cells for periods in excess of 5 weeks. Their abilities to support colony-forming units of granulocytes,macrophages (CFU-GM) and burst-forming units of erythroids (BFU-E) were almost equal to those of BM stromal cells. We observed similar results by using cloned TEC lines derived by limiting dilution, as well as those by using parental TEC lines. Colony-forming activities were maintained even when haematopoietic progenitor cells were physically separated from TEC lines and cultured on microporous membrane. These observations indicate that haematopoiesis maintained in TEC-contact long-term cultures may depend on soluble factors produced by TEC lines. Our results suggest that thymic cortical epithelial cells have the ability to support not only the differentiation of haematopoietic cells, but also long-term survival of clonogenic myeloid/erythroid progenitor cells. [source] Multilayer Amorphous-Si-B-C-N/,-Al2O3/,-Al2O3 Membranes for Hydrogen Purification,,ADVANCED ENGINEERING MATERIALS, Issue 6 2010Ravi Mohan Prasad Abstract The hydrogen and carbon monoxide separation is an important step in the hydrogen production process. If H2 can be selectively removed from the product side during hydrogen production in membrane reactors, then it would be possible to achieve complete CO conversion in a single-step under high temperature conditions. In the present work, the multilayer amorphous-Si-B-C-N/,-Al2O3/,-Al2O3 membranes with gradient porosity have been realized and assessed with respect to the thermal stability, geometry of pore space and H2/CO permeance. The ,-Al2O3 support has a bimodal pore-size distribution of about 0.64 and 0.045 µm being macroporous and the intermediate ,-Al2O3 layer,deposited from boehmite colloidal dispersion,has an average pore-size of 8,nm being mesoporous. The results obtained by the N2 -adsorption method indicate a decrease in the volume of micropores,0.35 vs. 0.75,cm3,g,1,and a smaller pore size ,6.8 vs. 7.4 Å,in membranes with the intermediate mesoporous ,-Al2O3 layer if compared to those without. The three times Si-B-C-N coated multilayer membranes show higher H2/CO permselectivities of about 10.5 and the H2 permeance of about 1.05,×,10,8 mol m,2 s,1 Pa,1. If compared to the state of the art of microporous membranes, the multilayer Si-B-C-N/,-Al2O3/,-Al2O3 membranes are appeared to be interesting candidates for hydrogen separation because of their tunable nature and high-temperature and high-pressure stability. [source] Danofloxacin-mesylate is a substrate for ATP-dependent efflux transportersBRITISH JOURNAL OF PHARMACOLOGY, Issue 4 2007J A Schrickx Background and purpose: Next to its broad antimicrobial spectrum, the therapeutic advantages of the fluoroquinolone antimicrobial drug Danofloxacin-Mesylate (DM) are attributed to its rapid distribution to the major target tissues such as lungs, intestines and the mammary gland in animals. Previous analyses revealed that effective drug concentrations are achieved also in luminal compartments of these organs, suggesting that active transport proteins facilitate excretion into the luminal space. Members of the ATP-Binding Cassette (ABC) superfamily, including P-gp, BCRP and MRP2 are known to be expressed in many tissue barriers and in cell-membranes facing luminal compartments. Hence we hypothesized that DM is a substrate for one of these efflux-transporters. Experimental approach: Confluent monolayers of Caco-2 cells, grown on microporous membranes in two-chamber devices were used. DM concentrations were measured by fluorimetric assay after HPLC of the culture media. Key results: DM transport across Caco-2 cells was asymmetric, with a rate of secretion exceeding that of absorption. The P-gp inhibitors PSC833 and GF120918 and the MRP-inhibitor MK571 partially decreased the secretion of DM and increased its absorption rate. The BCRP inhibitor, Ko143, decreased secretion only at a concentration of 1 ,M. When DM was applied together with ciprofloxacin, secretion as well as absorption of DM decreased. Conclusions and Implications: DM is a substrate for the efflux transporters P-gp and MRP2, whereas the specific role of BCRP in DM transport needs further evaluation. These findings provide a mechanistic basis for the understanding of the pharmacokinetics of DM in healthy and diseased individuals. British Journal of Pharmacology (2007) 150, 463,469. doi:10.1038/sj.bjp.0706974 [source] | ||||||||||